Desmidorchis retrospiciens
Desmidorchis retrospiciens · Accepted scientific name
Scientific literature: Very Sparse (1 studies) · ★☆☆☆☆
Desmidorchis retrospiciens is a unique botanical species currently being investigated for its significant therapeutic potential. Recent scientific inquiries have focused on its specific activities regarding anticancer properties. Researchers are particularly interested in how these biological effects can be harnessed to combat various forms of cancer. To study these medicinal qualities, the plant is most commonly processed as an alcohol extract. This method of preparation allows for the concentrated isolation of the bioactive compounds necessary for further study.
- Synonyms
- Stapelia Congestiflora · Stapelia Desmidorchis · 16 more
- Common names
- Not available
- Family
- Apocynaceae
- Distribution
- Southern America
- Plant Parts
- Not available
Classification
Common Names
Desmidorchis retrospiciens is a captivating plant known by a variety of evocative names across different languages and cultures. In English-speaking circles, it is frequently celebrated by the regal title of the king of Stapelia. It carries the descriptive Russian name Десмидорхис обратноколючковый, reflecting its unique physical characteristics. In Chinese contexts, it is honored with poetic monikers such as 孤独女王 and 锐角巨棱阁. These diverse names highlight the global fascination with this distinctive and striking species.
Sources: Catalogue of Life (COL)
Synonyms
Desmidorchis retrospiciens is a taxonomically complex species that has been identified under several different botanical names throughout history. It is closely linked to various synonyms, including the classifications of Boucerosia acutangula and Boucerosia russeliana. Furthermore, the plant has been documented as Boucerosia tombuctuensis in previous scientific literature. The evolutionary history of the species also connects it to the genus Caralluma, specifically through the names Caralluma acutangula and Caralluma hirtiflora. Understanding these shifting nomenclatural relationships is essential for accurate botanical identification and study.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Desmidorchis retrospiciens is a unique botanical specimen belonging to the vast kingdom Plantae. Within this expansive group, it is classified under the class Equisetopsida. The species is further defined by its placement in the order Gentianales. It falls under the specific family Apocynaceae, which helps researchers understand its evolutionary traits. Ultimately, this plant is identified by its distinct genus, Desmidorchis.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Gentianales |
| Family | Apocynaceae |
| Genus | Desmidorchis |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Desmidorchis retrospiciens is a plant species with a diverse geographic footprint across the African continent. Within East Tropical Africa, it can be found inhabiting the landscapes of both Kenya and Uganda. Its presence extends into Northeast Tropical Africa, where it thrives in the unique environments of Chad. Additionally, the species is documented within the borders of Djibouti and Eritrea. This wide distribution highlights the plant's ability to adapt to various regional ecosystems.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Desmidorchis retrospiciens is characterized by a distinctive shrub-like growth form. As a self-supporting species, it maintains its structure without the need for external assistance.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Desmidorchis retrospiciens, also known as Caralluma retrospiciens, has demonstrated significant anticancer activity through its unique chemical constituents. Research indicates that the methyl β-lilacinobioside isolated from this plant is capable of inhibiting cell proliferation and inducing apoptosis in human breast adenocarcinoma cell lines. This biological effect is achieved by regulating ROS-mediated autophagy and targeting topoisomerase II, which is essential for managing cancer cell division. Such findings provide scientific validation for the traditional medicinal uses of the plant observed among native inhabitants in southern Saudi Arabia. Consequently, this species represents a promising natural source for the development of new therapeutic agents to combat cancer.
Compounds
Conditions
Desmidorchis retrospiciens, referred to in the text as Caralluma retrospiciens, is utilized by native inhabitants for the treatment of cancer. Scientific evaluation has specifically demonstrated that this plant treats the human breast adenocarcinoma cell line (MCF-7) by inducing apoptosis. This therapeutic effect is attributed to the active constituent methyl β-lilacinobioside, which inhibits cell proliferation in these cancer cells. Furthermore, the plant belongs to a broader category of medicinal plants used by marginal communities to treat various ailments. These diverse applications highlight the significant medicinal potential of the species in addressing complex health issues.
Preparations
Desmidorchis retrospiciens is prepared as an alcohol extract to facilitate the isolation of specific chemical compounds. This extraction process was utilized to obtain pregnane glycosides from the aerial parts of the plant. Through this method, researchers successfully identified two distinct pregnane ester glycosides. The study employed advanced spectroscopic techniques, such as 2D NMR, to characterize the structures found within the extract. Consequently, this alcohol-based preparation provided the first report of these particular compounds from a natural source.